Quintet Private Bank (Europe)’s AstraZeneca AZN Stock Holding History

Quintet Private Bank (Europe)’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,605	Closed	-$404K	–	224
2024 Q1	$404K	Buy	+2,605	New	+$345K	0.02%	108
2023 Q3	–	Sell	-546	Closed	-$71.3K	–	254
2023 Q2	$71.3K	Buy	+546	New	+$80.3K	﹤0.01%	181
2022 Q2	$71.3K	Buy	+546	New	+$71.6K	﹤0.01%	181

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Quintet Private Bank (Europe)'s AZN Position: Q2 2024 in Review

Quintet Private Bank (Europe) sold out of AstraZeneca (AZN) in Q2 2024, closing a stake of 2,605 shares — an estimated $404K sold.

Quintet Private Bank (Europe) first reported a position in AZN in Q2 2022 and held it in 3 quarters. The position peaked at $404K in Q1 2024. 1,212 funds tracked by Wall St. Rank hold AZN as of Q2 2024.

Quintet Private Bank (Europe) reported no remaining AstraZeneca position as of Q2 2024 after selling out during the quarter.
Quintet Private Bank (Europe) sold 2,605 AstraZeneca shares in Q2 2024, an estimated $404K.
Quintet Private Bank (Europe) first reported a position in AstraZeneca in Q2 2022 and held it in 3 quarters.
Quintet Private Bank (Europe)'s AstraZeneca position peaked at $404K in Q1 2024.
1,212 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2024.

Based on Quintet Private Bank (Europe)'s 13F filing for Q2 2024, filed 24 Jul 2024.